| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $1.1M | +12.2% |
| SG&A Expense | $2.8M | -27.4% |
| Operating Income | -$7.7M | +2.8% |
| Pre-tax Income | -$7.7M | +11.8% |
| Income Tax | $0 | — |
| Net Income | -$7.7M | +11.8% |
| EPS (Basic) | -$5.60 | -65.2% |
| EPS (Diluted) | -$5.60 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | +17.8% |
| Accounts Receivable | $321 | -9.1% |
| Current Assets | $3.3M | +19.4% |
| Total Assets | $5.2M | -1.8% |
| Current Liabilities | $952K | +72.9% |
| Total Liabilities | $967K | +60.1% |
| Stockholders' Equity | $4.2M | -9.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | -10.6% |
| Investing Cash Flow | -$878K | +12.6% |
| Financing Cash Flow | $7.0M | -12.6% |
| -65.2% |